TY  - JOUR
AU  - Sant, Milena
AU  - Magri, Maria Chiara
AU  - Maurichi, Andrea
AU  - Lillini, Roberto
AU  - Bento, Maria Jose
AU  - Ardanaz, Eva
AU  - Guevara, Marcela
AU  - Innos, Kaire
AU  - Marcos-Gragera, Rafael
AU  - Rubio-Casadevall, Jordi
AU  - Sanchez-Perez, Maria-Jose
AU  - Tumino, Rosario
AU  - Rugge, Massimo
AU  - Minicozzi, Pamela
PY  - 2022
DO  - 10.3390/cancers14184379
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/20916
T2  - Cancers
AB  - Objectives: Standard care for cutaneous melanoma includes an accurate pathology report (PR) and sentinel lymph node biopsy (SLNB) for staging clinically node-negative >1 mm melanomas. We aimed to investigate the frequency of these indicators across...
LA  - en
PB  - MDPI AG
KW  - cutaneous melanoma
KW  - excess of relative risk of death
KW  - pathology report
KW  - population-based cancer registries
KW  - relative survival
KW  - sentinel lymph node biopsy
KW  - Humans
KW  - Melanoma
KW  - Skin Neoplasms
KW  - Sentinel Lymph Node Biopsy
KW  - Logistic Models
KW  - Portugal
KW  - Spain
KW  - Estonia
KW  - Hospitals, General
KW  - Odds Ratio
KW  - Melanoma, Cutaneous Malignant
KW  - Italy
KW  - Humans
KW  - Melanoma
KW  - Skin Neoplasms
KW  - Logistic Models
KW  - Portugal
KW  - Spain
KW  - Estonia
KW  - Hospitals, General
KW  - Odds Ratio
KW  - Melanoma, Cutaneous Malignant
KW  - Italy
TI  - Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations.
TY  - research article
VL  - 14
ER  -